Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Gerber, P. D.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Individualizing Therapy

right arrow Paul D. Gerber, MD

15 January 1994 | Volume 120 Issue 2 | Pages 170-171


TO THE EDITOR:

Dr. Alderman [1] is to be commended for shining a light on the "prevention paradox" [2] as applied to blood pressure management, thereby increasing awareness that prevention of disease is more complicated than it appears. Preventive interventions—proven in randomized controlled trials to reduce adverse outcomes—may have their largest effect on populations while conceivably harming single patients, particularly those whose absolute risks for the outcome studied are small and for whom intervention burdens are considerable. Risk-reducing interventions are most effective in individual patients when applied to patients at high risk for developing disease and those who already have disease, whether asymptomatic or symptomatic. Aiming intervention strategies to such patients to maximize the risk-to-benefit ratio to a single patient is clearly a less effective strategy for control of many diseases but is required by physicians taking the Hippocratic Oath to care for individual patients. Dr. Alderman nicely describes this general principle as it applies to blood pressure control and the reduction of cardiovascular end points.

Another aspect of this issue that he did not emphasize is the patient's perception of risk. Patients who are averse to risk might adopt any strategy, including those with troublesome burdens, to reduce their absolute risk, even if it is small.

At the other end of the spectrum, patients who are more likely to benefit personally from the proposed intervention may refuse it. They may be sensitive to intervention burdens such as labeling effects, side-effects, expense, loss of pleasure, and other poorly defined quality-of-life effects of our well-meaning attempts to reduce the burden of disease in populations. This is particularly true in patients who are risk takers.

Physicians can easily influence patients through framing effects when describing treatment options, and I would have enjoyed reading how Dr. Alderman presents information on blood pressure reduction to patients with a minimum of powerful framing effects and how he elicits and employs patient utilities to guide his individual patients toward optimal clinical decisions.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Dartmouth-Hitchcock Medical Center; Lebanon, NH 03756


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Alderman MH. Blood pressure management: individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med. 1993; 119:329-35.

2. Brown EY, Viscoli CM, Horowitz RI. Preventive health strategies and the policy makers' paradox. Ann Intern Med. 1992; 116:593-7.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Gerber, P. D.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online